483 Boehringer Ingelheim Fremont Feb 2010

483 Boehringer Ingelheim Fremont Feb 2010

Thomas Arista FDA, Peter Baker FDA, William Millar FDA$119.00 - Available Now

FDA investigators audited the Boehringer Ingelheim Fremont - Fremont, CA, United States facility and issued inspectional observations (via FDA 483) on 25 Feb 2010.

Add To Cart

Product details

  • Category: Human Drugs
  • Inspection end: 25 Feb 2010
  • Location: Fremont, United States